COMPARISON OF TWO KINETICS OF ADMINISTRATION OF BOLUS BY INSULIN PORTABLE PUMP ON THE GLUCOSE BLOOD STABILITY FOR INSULIN-DEPENDENT PATIENTS

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2006-005846-35-FR

Enrollment

Registered

2006-12-29

Start date

2007-02-07

Completion date

Unknown

Last updated

2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

INSULIN-DEPENDENT PATIENTS USING AN INSULIN PORTABLE PUMP MedDRA version: 9.1 Level: LLT Classification code 10012608 Term: Diabetes mellitus insulin-dependent

Interventions

Trade Name: NovoRapid Product Name: NA Product Code: NA Pharmaceutical Form: Solution for injection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: MEN AND WOMEN BETWEEN 18 AND 70 YEARS OLD INSULIN DEPENDENT PATIENTS WHICH ARE USING AN INSULIN PORTABLE PUMP WHICH CAN BE PROGRAMMED AND PERFUSING FAST INSULIN FOR 6 MONTHS Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: PREGNANCY WOMEN NURSING MOTHERS PATIENTS UNDER 18 AND MORE THAN 70 YEARS OLD ACUTE OR CHRONIC PATHOLOGY WHICH CAN IMPROVE WITH THE GLYCAEMIA METABOLIM

Design outcomes

Primary

Measure	Time frame
Main Objective: COMPARISON OF DISPERSION OF THE CAPILLARY GLYCAEMIA INTO THE TWO GROUPS;Secondary Objective: ;Primary end point(s):	—

Countries

France

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026